Actively Recruiting
Exploratory Study to Identify Predictive Factors of Clonal Evolution in Individuals with Germline GATA2 Mutation Using Retrospective and Prospective Data
Led by Institut Claudius Regaud · Updated on 2026-09-30
150
Participants Needed
24
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating subjects with germline GATA2 gene mutations to understand factors that predict clonal evolution in these individuals. This study includes both retrospective and prospective groups and aims to characterize the timing of certain clinical events over a 5-year period for each patient. It is an open-label, multi-site, interventional study involving 250 participants. Participants in the prospective group will provide biological samples such as blood and bone marrow at a baseline visit and during standard care over 5 years, without any additional sampling for the study. The retrospective group involves analysis of archived samples and clinical data from deceased or lost-to-follow-up patients previously identified with the mutation. No extra interventions beyond standard care are performed. Throughout the study, participants will be followed for clinical events related to their condition, with data collected from routine care visits and medical records. The primary outcome measures the time from birth to specific clinical events over 5 years. Secondary outcomes include time to other health events and disease-free survival. The study ensures ongoing monitoring without requiring additional procedures beyond standard medical practice.
CONDITIONS
Brief Title
Study for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline Mutation
Research Team
M
Marlène PASQUET
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here